Phase I/II Trial of Sorafenib in Combination with Vinorelbine as First-Line Chemotherapy for Metastatic Breast Cancer

BACKGROUND: Preclinical models have reported a synergistic interaction between sorafenib and vinorelbine. We investigated the toxicity, efficacy, and pharmacokinetics interaction of this combination as first-line treatment for patients with metastatic breast cancer. METHODS: Patients were HER2-negat...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferrario, Cristiano, Strepponi, Ivan, Esfahani, Khashayar, Charamis, Helen, Langleben, Adrian, Scarpi, Emanuela, Nanni, Oriana, Miller, Wilson H., Panasci, Lawrence C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5167316/
https://www.ncbi.nlm.nih.gov/pubmed/27992451
http://dx.doi.org/10.1371/journal.pone.0167906

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5167316/
https://www.ncbi.nlm.nih.gov/pubmed/27992451
http://dx.doi.org/10.1371/journal.pone.0167906

Ejemplares similares